date:Oct 15, 2021
s. In the past 18 months, Chr. Hansen divested its Natural Colors business and acquired HSO Health Care, UAS Labs and Jennewein.
According to CEO Mauricio Graber, the transactions have been successfully completed but not without challenges, especially Jennewein, which fell short of expectations for the year in part due to the human milk oligosaccharides (HMO) market developing more slowly than anticipated.
The companys outlook for 2021/22 eyes organic revenue growth of 5-8% and free cash flow